These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 24301243)

  • 1. The treatment and demographics of warts: an analysis of national trends.
    Reeder VJ; Gustafson CJ; Davis SA; Fleischer AB; Huang WW
    J Drugs Dermatol; 2013 Dec; 12(12):1411-5. PubMed ID: 24301243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of facial verrucae with topical imiquimod cream in a patient with human immunodeficiency virus.
    Cutler K; Kagen MH; Don PC; McAleer P; Weinberg JM
    Acta Derm Venereol; 2000; 80(2):134-5. PubMed ID: 10877136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imiquimod in the treatment of cutaneous warts: an evidence-based review.
    Ahn CS; Huang WW
    Am J Clin Dermatol; 2014 Oct; 15(5):387-99. PubMed ID: 25186654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical imiquimod for recalcitrant facial flat warts.
    Schwab RA; Elston DM
    Cutis; 2000 Mar; 65(3):160-2. PubMed ID: 10738635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiating effect of imiquimod in the treatment of verrucae vulgares in immunocompromised patients.
    Weisshaar E; Gollnick H
    Acta Derm Venereol; 2000; 80(4):306-7. PubMed ID: 11028871
    [No Abstract]   [Full Text] [Related]  

  • 6. [Often they heal spontaneously and the treatments are not always harmless: concerning warts waiting and seeing is a legitimate therapy].
    Neumaier J
    MMW Fortschr Med; 2006 Jun; 148(26):12-3. PubMed ID: 16875371
    [No Abstract]   [Full Text] [Related]  

  • 7. [Imiquimod in the treatment of recalcitrant warts: a new therapy option?].
    Hesterberg U; Böhlen LM; Brand CU
    Praxis (Bern 1994); 2003 Mar; 92(12):535-9. PubMed ID: 12693144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, comparative trial on the sustained efficacy of topical imiquimod 5% cream versus conventional ablative methods in external anogenital warts.
    Schöfer H; Van Ophoven A; Henke U; Lenz T; Eul A
    Eur J Dermatol; 2006; 16(6):642-8. PubMed ID: 17229604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five cases of recalcitrant plantar warts successfully treated with imiquimod 5% cream.
    López-Giménez MT
    Actas Dermosifiliogr; 2013 Sep; 104(7):640-2. PubMed ID: 23870849
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment of verrucae planae with imiquimod 5% cream.
    Niiyama S; Amoh Y; Katsuoka K
    Acta Dermatovenerol Croat; 2011; 19(4):273-4. PubMed ID: 22185930
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of flat warts with 5% imiquimod cream.
    Kim MB; Ko HC; Jang HS; Oh CK; Kwon KS
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1349-50. PubMed ID: 17062069
    [No Abstract]   [Full Text] [Related]  

  • 12. 5% topical imiquimod tolerance in transplant recipients.
    Ben M'barek L; Mebazaa A; Euvrard S; Frances C; Thervet E; Morel P; Menasché S; Legendre C; Lebbe C
    Dermatology; 2007; 215(2):130-3. PubMed ID: 17684375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vagarious successful treatment of recalcitrant warts in combination with CO2 laser and imiquimod 5% cream.
    Zeng Y; Zheng YQ; Wang L
    J Cosmet Laser Ther; 2014 Dec; 16(6):311-3. PubMed ID: 25148409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Partial efficacy of imiquimod on plantar warts in immunodeficient patients].
    Dupin N; Soubrane O; Escande JP
    Ann Dermatol Venereol; 2003 Feb; 130(2 Pt 1):210-1. PubMed ID: 12671588
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost of pain medication to treat adult patients with nonmalignant chronic pain in the United States.
    Rasu RS; Vouthy K; Crowl AN; Stegeman AE; Fikru B; Bawa WA; Knell ME
    J Manag Care Spec Pharm; 2014 Sep; 20(9):921-8. PubMed ID: 25166291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical imiquimod associated to a reduction of heel hyperkeratosis for the treatment of recalcitrant mosaic plantar warts.
    Mitsuishi T; Wakabayashi T; Kawana S
    Eur J Dermatol; 2009; 19(3):268-9. PubMed ID: 19286492
    [No Abstract]   [Full Text] [Related]  

  • 17. Imiquimod: a new possibility for treatment-resistant verrucae planae.
    Oster-Schmidt C
    Arch Dermatol; 2001 May; 137(5):666-7. PubMed ID: 11346354
    [No Abstract]   [Full Text] [Related]  

  • 18. Imiquimod in clinical practice.
    Edwards L
    Australas J Dermatol; 1998 Nov; 39 Suppl 1():S14-6. PubMed ID: 9842096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of imiquimod versus podophyllotoxin in the treatment of anogenital warts.
    Komericki P; Akkilic-Materna M; Strimitzer T; Aberer W
    Sex Transm Dis; 2011 Mar; 38(3):216-8. PubMed ID: 20938374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy-resistant disseminated verrucae in an atopic patient with cellular immunodeficiency--successful topical treatment with imiquimod].
    Djawari D
    J Dtsch Dermatol Ges; 2003 Jul; 1(7):565-7. PubMed ID: 16295042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.